95 related articles for article (PubMed ID: 30272320)
21. Genome-wide profiles of metastasis-associated mRNAs and microRNAs in salivary adenoid cystic carcinoma.
Wang S; Zhang L; Shi P; Zhang Y; Zhou H; Cao X
Biochem Biophys Res Commun; 2018 Jun; 500(3):632-638. PubMed ID: 29678584
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
23. MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses.
Shi L; Zhao SM; Luo Y; Zhang AW; Wei LH; Xie ZY; Li YY; Ma W
Pathol Res Pract; 2017 Nov; 213(11):1344-1354. PubMed ID: 29033189
[TBL] [Abstract][Full Text] [Related]
24. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.
Nieto HR; Thornton CEM; Brookes K; Nobre de Menezes A; Fletcher A; Alshahrani M; Kocbiyik M; Sharma N; Boelaert K; Cazier JB; Mehanna H; Smith VE; Read ML; McCabe CJ
J Clin Endocrinol Metab; 2022 Apr; 107(5):1392-1406. PubMed ID: 34791326
[TBL] [Abstract][Full Text] [Related]
28. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
29. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
30. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
31. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
32. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
33. Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).
Hoelting T; Goretzki PE; Duh QY
Oncol Rep; 2001; 8(1):3-8. PubMed ID: 11115561
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
35. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
[TBL] [Abstract][Full Text] [Related]
36. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin.
Westbury C; Vini L; Fisher C; Harmer C
Thyroid; 2000 Feb; 10(2):171-6. PubMed ID: 10718555
[TBL] [Abstract][Full Text] [Related]
37. Microscopic Positive Tumor Margin Does Not Increase the Risk of Recurrence in Patients with T1-T2 Well-Differentiated Thyroid Cancer.
Kluijfhout WP; Pasternak JD; Kwon JS; Lim J; Shen WT; Gosnell JE; Khanafshar E; Duh QY; Suh I
Ann Surg Oncol; 2016 May; 23(5):1446-51. PubMed ID: 26628431
[TBL] [Abstract][Full Text] [Related]
38. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
Hoelting T; Duh QY; Clark OH; Herfarth C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
[TBL] [Abstract][Full Text] [Related]
39. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
40. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
